Searchable abstracts of presentations at key conferences in endocrinology

ea0020p60 | Thyroid | ECE2009

The value of TSH-assisted 18F-FDG PET in initial stage M0 thyroid carcinoma with suspicion of residual or recurrent disease

Taieb David , Ghander Cecile , Sebag Frederic , Tessonnier Laurent , Palazzo F Fausto , De Micco Catherine , Henry Jean-Francois , Mundler Olivier

Purpose: Persistence of well-differentiated thyroid carcinoma most commonly involves cervical lymph nodes. The purposes of the study were to evaluate the ability of FDG-PET/CT imaging to localize residual disease in initial stage M0 thyroid carcinoma thyroid cancer patients and to compare FDG-PET/CT to neck US.Methods: FDG-PET/CT and neck US results of 93 patients were retrospectively analysed. All FDG-PET/CT were performed during thyrotropin stimulation...

ea0020p189 | Endocrine tumours and neoplasia | ECE2009

Tumor/liver standardized uptake values ratio <1.8 on FDG-PET has a high negative predicitive value to rule-out malignancy in patients with incidentally identified non-secreting adrenal tumours

Taieb David , Tessonnier Laurent , Sebag Frederic , Morange Isabelle , De Micco Catherine , Conte-Devolx Bernard , Henry Jean-Francois , Mundler Olivier

Purpose: The widespread use of high resolution cross-sectional imaging such as computer tomography (CT) and magnetic resonance imaging (MRI) for the investigation of the abdomen is associated with an increasing detection of incidental adrenal masses. 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) has proved to be an efficient tool in the diagnosis and follow-up of malignancies. We evaluated the ability of FDG-PET to distinguish benign from malignant adrenal mass...